Naringenin induces mitochondria-mediated apoptosis and endoplasmic reticulum stress by regulating MAPK and AKT signal transduction pathways in endometriosis cells
Lab / animal
OA: bronze
CC0
⤵ 27 in-corpus citations
AI-generated summary
Naringenin suppresses endometriosis cell proliferation and induces apoptosis by regulating MAPK and AKT pathways, leading to mitochondrial dysfunction and endoplasmic reticulum stress.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Does the flavonoid naringenin inhibit proliferation of human endometriosis cells?
SUMMARY ANSWER: Naringenin suppresses proliferation and increases apoptosis via depolarization of mitochondrial membrane potential and generation of reactive oxygen species (ROS) in human endometriosis cells.
WHAT IS KNOWN ALREADY: For management of endometriosis, hormonal therapy is commonly used to decrease production of estrogens by the ovaries, but that has limitations including undesirable side effects with long-term therapies. To overcome these limitations, it is important to discover novel compounds which have no adverse effects, but inhibit expression of target molecules involved in the pathogenesis of endometriosis.
STUDY DESIGN SIZE, DURATION: Well-established endometriosis cell lines (VK2/E6E7 and End1/E6E7) were purchased from the American Type Culture Collection. Effects of naringenin on VK2/E6E7 and End1/E6E7 cells were assessed in diverse assays in a dose- and time-dependent manner.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Effects of naringenin on viability, apoptosis (Annexin V expression, propidium iodide staining, TUNEL and invasion assays), mitochondria-mediated apoptosis, production of ROS and endoplasmic reticulum (ER) stress proteins of VK2/E6E7 and End1/E6E7 cells were determined. Signal transduction pathways in VK2/E6E7 and End1/E6E7 cells in response to naringenin were determined by western blot analyses.
MAIN RESULTS AND THE ROLE OF CHANCE: In the present study, we demonstrated that naringenin suppressed proliferation and increased apoptosis through depolarization of mitochondrial membrane potential and inducing pro-apoptotic proteins, Bax and Bak, in both endometriosis cell lines. In addition, naringenin increased ROS, ER stress, through activation of eIF2α and IRE1α, GADD153 and GRP78 proteins in a dose-dependent manner. Furthermore, the induction of apoptosis by naringenin involved activation of MAPK and inactivation of PI3K pathways in VK2/E6E7 and End1/E6E7 cells.
LIMITATIONS REASONS FOR CAUTION: Lack of in vivo animal studies is a major limitation of this research. Effectiveness of naringenin to induce apoptosis of human endometriosis cells requires further investigation.
WIDER IMPLICATIONS OF THE FINDINGS: Our results suggest that naringenin is a promising therapeutic compound for treatment of endometriosis in women.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (No. HI15C0810 awarded to G.S. and HI17C0929 awarded to W.L.). The authors declare that there are no conflicts of interest.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (49)
- Actuarial analysis of private payer administrative claims data for women with endometriosis via openalex
- Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model via openalex
- Can specific pain symptoms help in the diagnosis of endometriosis? A cohort study of women with chronic pelvic pain via openalex
- Clinical practice. Endometriosis via openalex
- Consensus on current management of endometriosis via openalex
- Endometriosis via openalex
- Endometriosis and infertility: a committee opinion via openalex
- Endometriosis and infertility: pathophysiology and management via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis via openalex
- Lipid peroxidation and vitamin E in serum and follicular fluid of infertile women with peritoneal endometriosis submitted to controlled ovarian hyperstimulation: a pilot study via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- Non-invasive diagnosis of endometriosis: the goal or own goal? via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Pelvic endometriosis diagnosed in an entire nation over 20 years via openalex
- Possible pathophysiological roles of mitogen-activated protein kinases (MAPKs) in endometriosis via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Reactive oxygen species controls endometriosis progression via openalex
- The role of NF-kappaB in endometriosis via openalex
- Validation study of nonsurgical diagnosis of endometriosis via openalex
- 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis via openalex
- W2136997516 via openalex
- W2155945227 via openalex
- W2160349672 via openalex
- W2170519509 via openalex
- W2292633092 via openalex
- W2293368815 via openalex
- W2519719294 via openalex
- W2206304062 via openalex
- W1585019003 via openalex
- W1965594273 via openalex
- W1973425537 via openalex
- W1989406924 via openalex
- W1989863622 via openalex
- W1993897315 via openalex
- W2005408613 via openalex
- W2006641123 via openalex
- W2007293096 via openalex
- W2015065898 via openalex
- W2032080607 via openalex
- W2050658126 via openalex
- W2057864547 via openalex
- W2074467787 via openalex
- W2078120251 via openalex
- W2079190330 via openalex
- W2081561608 via openalex
- W2104692302 via openalex
- W2129176808 via openalex
- W2130203785 via openalex
Cited by (37)
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression 2026
- Revisiting endometriosis management: Polyphenols as alternative therapeutic candidates 2026
- Metabolic remodeling of endometriosis microenvironment: Energy stress and immune evasion 2026
- Computational identification of natural CXCR4-binding candidates relevant to endometriosis and ovarian cancer progression 2026
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Phytochemicals Modulating Receptor Tyrosine Kinase Signaling Networks in Endometriosis 2026
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Identified endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis 2025
- Mitochondrial Involvement in the Pathogenesis of Endometriosis and its Potential as Therapeutic Targets 2025
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Phytoestrogens: A Promising Therapeutic Approach for Endometriosis Management, Insights from Preclinical and Clinical Studies 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- Bioinformatic analysis reveals endoplasmic reticulum stress-related molecular cluster and immune characterization in endometriosis:implications for disease subtyping and therapeutic strategies 2024
- Endometriosis: A Comprehensive and Concise Review of Potential Biomarkers and Treatment Therapies 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Identification and validation of an endoplasmic-reticulum-stress-related gene signature as an effective diagnostic marker of endometriosis 2024
- The role of endoplasmic reticulum stress in endometriosis 2023
- The Role of Herbal Medicine as An Alternative Treatment Option for Endometriosis: A Literature Review 2023
- The Role of mTOR and eIF Signaling in Benign Endometrial Diseases 2022
- Mechanism Study of Cinnamomi Ramulus and Paris polyphylla Sm. Drug Pair in the Treatment of Adenomyosis by Network Pharmacology and Experimental Validation 2022
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets? 2021
- Molecular Mechanistic Pathways Targeted by Natural Antioxidants in the Prevention and Treatment of Chronic Kidney Disease 2021
- An Overview on the Conservative Management of Endometriosis from a Naturopathic Perspective: Phytochemicals and Medicinal Plants 2021
- Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review 2021
- Modular Characteristics and Mechanism of Action of Herbs for Endometriosis Treatment in Chinese Medicine: A Data Mining and Network Pharmacology-Based Identification 2020
- Protective effect of cabergoline on mitochondrial oxidative stress-induced apoptosis is mediated by modulations of TRPM2 in neutrophils of patients with endometriosis 2020
- Naringenin ameliorates progression of endometriosis by modulating Nrf2/Keap1/HO1 axis and inducing apoptosis in rats 2019
- Quercetin inhibits proliferation of endometriosis regulating cyclin D1 and its target microRNAs in vitro and in vivo 2018
- Chrysin leads to cell death in endometriosis by regulation of endoplasmic reticulum stress and cytosolic calcium level 2018
- Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms 2018
Source provenance
- europepmc
- last seen: 2026-10-13T06:10:10.580696+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:20:50.926721+00:00
License: CC0
· commercial use OK